Form 4 for MRNA Moderna
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008715 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | +2,606 | 1.63M | +0.2% | $0 |
| D | 2023-03-03 | 2023-03-02 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $136.43 | -1,177 | 1.63M | -0.1% | -$160.6K |
| D | 2023-03-03 | 2023-03-01 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -2,606 | 7,819 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 2,606 | $0.00 | 1,631,637 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-02 | S | D | 1,177 | $136.43 | 1,630,460 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-01 | M | D | 2,606 | $0.00 | 7,819 | D | $0.00 · — to — | 2,606 Common Stock | (F4) 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |